Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8024661 | 0.86 | PPARG (0.49) | PPARGPPARA | |
| SCHEMBL28417484 | 0.85 | PPARG (0.61) | PPARGPPARA | |
| SCHEMBL940490 | 0.84 | PPARG (0.58) | PPARGPPARA | |
| SCHEMBL10735245 | 0.83 | PPARG (0.44) | PPARGPPARA | |
| SCHEMBL21057234 | 0.82 | LDHA (0.61) | PPARGPPARA | |
| SCHEMBL21057232 | 0.82 | LDHA (0.61) | PPARGPPARA | |
| SCHEMBL1874697 | 0.82 | PPARG (0.70) | PPARGPPARA | |
| SCHEMBL4651839 | 0.82 | SMN1; SMN2 (0.64) | PPARGPPARA | |
| SCHEMBL11501300 | 0.82 | PPARG (0.57) | PPARGPPARA | |
| SCHEMBL4300663 | 0.82 | PPARG (0.58) | PPARGPPARA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 164 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025264177-A1 | METHOD FOR CLEAVING PROTECTING GROUPS AND ORGANIC COMPOUNDS FROM SUPPORTS | POLYPEPTIDE LABORATORIES HOLDING (PPL) AB (SE) | 2025-12-26 | — | — | WO | claimed |
| US-20180259510-A1 | NON-COVALENT PATTERNED CHEMICAL FEATURES AND USE THEREOF IN MALDI-BASED QUALITY CONTROL | NATIONAL SCIENCE FOUNDATION | 2018-09-13 | — | — | US | claimed |
| US-20160041158-A1 | NON-CONVALENT PATTERNED CHEMICAL FEATURES AND USE THEREOF IN MALDI-BASED QUALITY CONTROL | NATIONAL SCIENCE FOUNDATION | 2016-02-11 | — | — | US | claimed |
| CN-103314010-B | Solid phase synthesis of h(gly2)glp-2 | NYCOMED GMBH | 2015-03-04 | — | — | CN | claimed |
| WO-2014144383-A1 | NON-COVALENT PATTERNED CHEMICAL FEATURES AND USE THEREOF IN MALDI-BASED QUALITY CONTROL | ARIZONA BOARD OF REGENTS, A BODY CORPORATE OF THE STATE OF ARIZONA, ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY (US) | 2014-09-18 | — | — | WO | claimed |
| CN-103314010-A | Solid phase synthesis of h(gly2)glp-2 | NYCOMED GMBH | 2013-09-18 | — | — | CN | claimed |
| EP-1679318-A1 | Process for folding chemically synthesized polypeptides | RMF DICTAGENE S.A. (CH) | 2006-07-12 | — | — | EP | claimed |
| EP-1337549-B1 | PROCESS FOR FOLDING CHEMICALLY SYNTHESIZED POLYPEPTIDES | RMF DICTAGENE SA (CH) | 2006-04-05 | — | — | EP | claimed |
| US-20050239162-A1 | Process for folding chemically synthesized polypeptides | RMF DICTAGENE S.A. (CH) | 2005-10-27 | — | — | US | claimed |
| EP-1337549-A2 | PROCESS FOR FOLDING CHEMICALLY SYNTHESIZED POLYPEPTIDES | RMF DICTAGENE S.A. (CH) | 2003-08-27 | — | — | EP | claimed |
| WO-2002053578-A2 | NOVEL APPLICATIONS FOR AN ANION EXCHANGE RESIN (EPM-8) | CONSELHO NACIONAL DE DESENVOLVIMENTO CIENTIFICO E TECNOLOGICO - CNPQ (BR) | 2002-07-11 | — | — | WO | claimed |
| WO-2002050099-A2 | PROCESS FOR FOLDING CHEMICALLY SYNTHESIZED POLYPEPTIDES | RMF DICTAGENE S.A. (CH) | 2002-06-27 | — | — | WO | claimed |
| US-20020082384-A1 | Process for folding chemically synthesized polypeptides | RMF DICTAGENE S.A. (CH) | 2002-06-27 | — | — | US | claimed |
| US-5286789-A | Clear polystyrene functionalized with linking groups | APPLIED IMMUNE SCIENCES, INC. (US) | 1994-02-15 | — | — | US | claimed |
| WO-2025264177-A1 | METHOD FOR CLEAVING PROTECTING GROUPS AND ORGANIC COMPOUNDS FROM SUPPORTS | POLYPEPTIDE LABORATORIES HOLDING (PPL) AB (SE) | 2025-12-26 | — | — | WO | disclosed |
| US-20250282825-A1 | NOVEL CYCLIC COMPOUNDS, METHOD FOR THEIR PREPARATION AND THE USE OF SAID CYCLIC COMPOUNDS IN COSMETIC PREPARATIONS | EBERHARD KARLS UNIVERSITAET TUEBINGEN (DE) | 2025-09-11 | — | — | US | disclosed |
| CN-110662759-B | Tumor targeting peptide variants | 癌症研究技术有限公司 | 2024-03-08 | — | — | CN | disclosed |
| EP-0400920-A1 | Solid phase multiple peptide synthesis | RHONE-POULENC RORER PHARMACEUTICALS INC. (US) | 1990-12-05 | — | — | EP | disclosed |
| EP-0352560-A1 | Novel peptides | KAO CORPORATION (JP) | 1990-01-31 | — | — | EP | disclosed |
| US-4508541-A | DETERGENTS | TEXACO INC. (US) | 1985-04-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250282825-A1 | NOVEL CYCLIC COMPOUNDS, METHOD FOR THEIR PREPARATION AND THE USE OF SAID CYCLIC COMPOUNDS IN COSMETIC PREPARATIONS | ODC1, NISCH, CUTA | PPARG 208/4885PPARA 237/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.